3136 results for «358»
3136 results
Transcatheter solutions in young and congenital heart disease patients
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter solutions tailored for young and congenital heart disease patients, featuring challenging edge-to-edge repair in extracardiac Fontan physiology, systemic AV valve TEER in congenital anomalies, multidisciplinary management of repaired tetralogy of Fallot with tricuspid regurgitation, innovative TAVI in young congenital patients, and...
TAVI: technical tips and tricks
18 Nov 2025 – From PCR London Valves 2025
This session provides practical technical guidance for TAVI procedures emphasizing multimodality imaging for ultra-low contrast implantation, contrast-free techniques tailored for type 0 bicuspid aortic valves, and innovative bailout strategies for rapid pacing failure. It also covers advanced access management approaches in contrast-zero TAVI and current commissural...
TAVI complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session explores complex and uncommon complications associated with TAVI procedures, highlighting challenging clinical scenarios such as neurological complications in bicuspid valves, management of critically unstable left ventricles, and outcomes in complex valve interventions. Each topic offers valuable lessons for improving procedural safety and patient outcomes...
Complications of mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session addresses complications associated with mitral transcatheter edge-to-edge repair (TEER), showcasing innovative bailout methods such as snare-assisted retrieval of undeployed devices, managing leaflet perforations with latest-generation devices, cases of valve-adjacent tears, mechanical support considerations when pumps fail, and the clinical impact of iatrogenic fossa ovalis...
Thrombotic complications of transcatheter valves
17 Nov 2025 – From PCR London Valves 2025
Focusing on thrombotic complications following transcatheter valve implantation, this session presents a series of complex cases illustrating acute and late thrombotic events, their clinical presentations, and the pivotal role of multimodality imaging in diagnosis and management. Insights include coronary embolism and cardiogenic shock scenarios, emphasizing challenges...
TAVI: coronary protection
17 Nov 2025 – From PCR London Valves 2025
This session addresses coronary protection strategies during TAVI procedures, especially in complex scenarios such as valve-in-valve interventions, small annulus, and high-risk anatomy. It covers advanced techniques like BASILICA and bioprosthetic valve fracture, providing expert guidance on overcoming challenges to prevent coronary artery obstruction and optimize procedural...
TAVI-in-TAVI - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session explores the evolving field of TAVI-in-TAVI interventions, presenting complex cases such as transfemoral TAVI-in-TAVI for degenerated transapical clip-fixed valves in transplanted hearts, management of very late TAVI migration in Bentall de Bono patients, TAVI for degenerated Evolut R valves, stepwise approaches to coronary protection...
TAVI: unusual complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session reviews unusual and severe complications encountered during TAVI procedures, such as aorto-right ventricular fistula, ventricular perforation, and sinus of Valsalva rupture. It highlights percutaneous treatment successes and endovascular interventions, offering critical insights into managing life-threatening procedural complications effectively.
Curious TAVI scenarios - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session examines unusual and challenging clinical scenarios following TAVI, including presentations of cyanosis, evolving valvular defects such as growing paravalvular holes, atypical imaging findings, paradoxical transvalvular gradients switching from aortic regurgitation to stenosis resolved by postdilatation, and bicoronary protection techniques in patients with low coronary...
Complications of valve-in-valve TAVI
18 Nov 2025 – From PCR London Valves 2025
This session addresses the complex complications associated with valve-in-valve TAVI procedures. Topics include delayed coronary compromise, unexpected clinical scenarios, the importance of recognizing surgical bioprosthesis types, the dual role of calcium in TAVI, and intricate left ventricular complications that can arise post valve-in-valve interventions.
Transcatheter tricuspid valve replacement: pioneering techniques and solutions for high-risk patients
18 Nov 2025 – From PCR London Valves 2025
This session explores advanced transcatheter tricuspid valve replacement techniques and outcomes. It features cases of TricValve dysfunction due to intrinsic regurgitation, pioneering 'chimney technique' implantation in complex patients, right heart remodeling post-intervention, and innovative solutions including percutaneous heterotopic bicaval valve implantation following pericardiectomy.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
